You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Breast cancer (BRCA) 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • blood sample for BRCA2 mutation detection
  • (no location specified)
Jun 1, 2023

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Germline BRCA-mutated HER2-negative Breast Cancer Trial in Beijing (Camrelizumab+Fluzoparib)

Enrolling by invitation
  • Germline BRCA-mutated HER2-negative Breast Cancer
  • Beijing, Beijing, China
    Breast Cancer, Peking University People's Hospital
Nov 14, 2022

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

Not yet recruiting
  • Breast Cancer
  • Questionnaires
  • Communication of the results of the BRCA1/2 ultra rapid test
  • (no location specified)
Oct 26, 2023

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    Breast Cancer After Ovarian Cancer During and/or After Therapy:

    Recruiting
    • BRCA-Associated Breast Carcinoma
    • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 9, 2023

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Jan 9, 2023

      Breast Tumor Female Trial in United Kingdom (Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform,

      Active, not recruiting
      • Breast Neoplasm Female
      • Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform
      • Digital Delivery of Genetic Test Results via the BRCA-DIRECT Platform
      • Manchester, England, United Kingdom
      • +4 more
      Aug 12, 2022

      Breast Cancer Trial in New York (core needle biopsy, blood draw)

      Recruiting
      • Breast Cancer
      • core needle biopsy
      • blood draw
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Nov 9, 2023

      Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

      Recruiting
      • Pancreatic Adenocarcinoma Metastatic
      • +14 more
      • Boston, Massachusetts
      • +1 more
      Dec 6, 2022

      Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

      Recruiting
      • Hereditary Breast and Ovarian Cancer
        • Barcelona, Spain
          Hospital de la Santa Creu i Sant Pau
        Jun 3, 2022

        l, Laboratory and Epidemiologic Characterization of Individuals

        Completed
        • Familial Ovarian Cancer
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 31, 2022

          Searching for Novel Germline Mutations in Lobular Breast Cancer

          Recruiting
          • Lobular Breast Carcinoma
          • +3 more
          • Illumina panel
          • Milan, Italy
            European Institute of Oncology
          Sep 12, 2022

          InheriteD brEast caNcer iTalian regIsTrY A

          Recruiting
          • Breast Cancer
            • Aviano, Pordenone, Italy
            • +11 more
            Apr 26, 2023

            Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by

            Completed
            • Breast Cancer
            • Blood test
            • Questionnaire
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Dec 27, 2021

            Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

            Active, not recruiting
            • Hereditary Breast and Ovarian Cancer
            • Structured exercise training plus mediterranean diet
            • Cologne, Germany
            • +2 more
            Oct 25, 2022

            Breast Cancer Metastatic Trial in Beijing (TSL-1502 capsules(low dose), TSL-1502 capsules(high dose), Investigator's choice of

            Not yet recruiting
            • Breast Cancer Metastatic
            • TSL-1502 capsules(low dose)
            • +2 more
            • Beijing, China
              Cancer Hospital, Chinese Academy of Medical Sciences
            Jun 13, 2022

            Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

            Recruiting
            • Advanced Breast Carcinoma
            • +14 more
            • Houston, Texas
              M D Anderson Cancer Center
            Mar 31, 2022